Hikal Limited in a significant move to enhance the productivity of the pharma industry has tied up with Rockwell Automation, the leading industrial automation company as an Enterprise Integration Partner, for handling medium to large complex projects integrating ERP systems with real time systems. Hikal aims to provide information and control systems from "Shop Floor to Top Floor".

Hikal's IT division is strategically focused on increasing efficiency of pharma manufacturers by addressing issues like reducing costs, conserving resources, improving productivity and reducing the time to market for material goods and services. This is done by the `Total Integration of the Enterprise.'

It has a strong technical base in enterprise integration applications including ERP, communication, etc., while Rockwell Automation is a leader in automation & control system segment.

The synergy between Hikal Ltd. and Rockwell Automation is a unique synthesis, which offers total industrial information technology and control solutions in the pharmaceutical area including 21 CFR Part 11 compliant solutions.

Hikal Limited, a global growth company is expanding its business internationally through collaborations with reputed corporations. With the acquisition of the Bangalore unit in South India in 2001, pharmaceuticals have come to enjoy a special focus at Hikal. The company has made a name for itself in the areas of crop protection chemicals, active pharmaceutical ingredients (APIs) and R&D. Hikal is putting up a new dedicated US FDA approved manufacturing facility for API (active pharmaceuticals ingredients) at Bangalore. This is expected to be completed by end 2002 and will facilitate the entry of Hikal into the USA market.

Hikal Limited is involved in custom synthesis and toll manufacture of pharmaceuticals, agrochemicals and intermediates. The company has manufacturing facilities at Taloja, Mahad, Panoli and now Bangalore. The areas of expertise include synthesis of chemical entities for drug development, natural products chemistry, analytical development for drugs and pharmaceuticals formulation development.